Top

Reactions Weekly

Published in:

01-11-2023 | Montelukast | Case report

Budesonide/Montelukast/Salbutamol

Worsening of tachycardia, shortness of breath and chest discomfort

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Umscheid JD, et al. Thyroid Hormone Resistance Syndrome Presenting as Exercise Induced Asthma. Journal of the Endocrine Society 5 (Suppl. 1): A707-A708, May 2021. Available from: URL: https://dx.doi.org/10.1210/jendso/bvab048.1441 [abstract]

Title: Budesonide/Montelukast/Salbutamol
Worsening of tachycardia, shortness of breath and chest discomfort
Publication date: 01-11-2023
Publisher: Springer International Publishing
Keywords: Montelukast
Salbutamol
Budesonide
Tachyarrythmia
Bronchial Asthma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-50353-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Budesonide/Montelukast/Salbutamol

Worsening of tachycardia, shortness of breath and chest discomfort

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Bromocriptine/cabergoline

Antineoplastics

Paclitaxel

Multiple drugs

Multiple drugs

Lenvatinib